US Patent Issued to NEURODAWN PHARMACEUTICAL on Sept. 15 for "Application of riluzole- and borneol-containing composition in preparation of medication for treating cerebrovascular diseases" (Chinese Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,158, issued on Sept. 15, was assigned to NEURODAWN PHARMACEUTICAL Co. LTD. (Nanjing, China).

"Application of riluzole- and borneol-containing composition in preparation of medication for treating cerebrovascular diseases" was invented by Zhengping Zhang (Nanjing, China), Lei Wang (Jiangsu, China) and Rong Chen (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A composition applied to preparation of a medicament for treating cerebrovascular diseases, in particular ischemic cerebrovascular diseases. The composition contains 2-amino-6-trifluoromethoxybenzothiazole or a pharmaceutically acceptable salt thereof and borneol. By means of the ...